Levosimendan Use Increases Cardiac Performance after Coronary Artery Bypass Grafting in End-Stage Renal Disease Patients


Atalay H., Temizturk Z., Altinsoy H. B. , Azboy D., Colak S., Atalay A., ...Daha Fazla

HEART SURGERY FORUM, cilt.19, 2016 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 19 Konu: 5
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1532/hsf.1426
  • Dergi Adı: HEART SURGERY FORUM

Özet

Background: The effect of levosimendan on myocardial performance has not been studied in dialysis-dependent end-stage renal disease patients who have undergone coronary artery bypass grafting (CABG) surgery. Our aim was to investigate the effect of levosimendan on postoperative hemodynamic effects in end-stage renal disease patients undergoing CABG operation.